- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Locally Advanced NSCLC in France
Total 722 results
-
AmgenNo longer availableNon Small-cell Lung Cancer | Locally Advanced Unresectable NSCLC | Locally Advanced Metastatic NSCLCUnited States, Taiwan, Israel, Saudi Arabia, Brazil, Argentina
-
Hospices Civils de LyonUnknownMetastatic or Locally Advanced Solid TumorsFrance
-
Pierre Fabre MedicamentTerminatedLocally Advanced or Metastatic Solid TumorsFrance, Spain
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, Spain, France, Italy, Korea, Republic of, Poland
-
Amunix, a Sanofi CompanyMerck Sharp & Dohme LLCRecruitingLocally Advanced or Metastatic HER2-Expressing CancersAustralia, Spain, France, Portugal
-
Institut Claudius RegaudMerck KGaA, Darmstadt, GermanyCompletedLocally Advanced Non Small Cell Lung Cancer (NSCLC)France
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany
-
National Cancer Institute (NCI)SuspendedLocally Advanced Leiomyosarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Locally Advanced Liposarcoma | Locally Advanced Undifferentiated Pleomorphic Sarcoma | Locally Advanced Extraskeletal Myxoid Chondrosarcoma | Locally Advanced Unresectable Soft Tissue SarcomaUnited States, Canada
-
Centre Oscar LambretCanceropôle Nord OuestRecruitingSarcoma Metastatic | Locally Advanced Soft Tissue SarcomaFrance
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Locally Advanced Bladder Urothelial Carcinoma | Locally Advanced Renal Pelvis Urothelial... and other conditionsUnited States
-
AstraZenecaCompletedEGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.Italy, Spain, United Kingdom, Sweden, Japan, Netherlands, Germany, France
-
Gilead SciencesEverest MedicinesActive, not recruitingLocally Advanced or Metastatic Unresectable Urothelial CancerUnited States, Belgium, France, Spain, United Kingdom, Korea, Republic of, Czechia, Germany, Israel, China, Italy, Australia, Hong Kong, Taiwan, Portugal, Singapore, Croatia, Greece, Turkey, Sweden, Switzerland, Canada, Austria, Bulgaria and more
-
PfizerTerminatedLocally Advanced or Metastatic Solid Tumors | Genes, BRCA 1United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Solid TumoursUnited States, Spain, Canada, Korea, Republic of
-
Center Eugene MarquisCompletedLocally Advanced Malignant Neoplasm | Malignant Neoplasm of Head and NeckFrance
-
Centre Hospitalier Universitaire DijonRecruitingLocally Advanced or Metastatic Small Bowel AdenocarcinomaFrance
-
Centre Antoine LacassagneRecruitingMetastatic or Locally-advanced Digestive CancerFrance
-
Tango Therapeutics, Inc.RecruitingLocally Advanced Solid TumorUnited States, Spain, France
-
Centre Jean PerrinGroupement Inter-Régional de Recherche Clinique et d'Innovation Auvergne...RecruitingLocally Advanced Head and Neck CarcinomaFrance
-
Tango Therapeutics, Inc.RecruitingLocally Advanced Solid TumorUnited States, France
-
Institut du Cancer de Montpellier - Val d'AurelleRecruitingLocally Advanced Pancreatic AdenocarcinomaFrance
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more
-
TakedaCompletedProstatic Neoplasms, Locally AdvancedFrance
-
Centre Oscar LambretUniversity Hospital, LilleTerminated
-
Toray Industries, IncCompletedCholangiocarcinoma | Colon Cancer | Locally Advanced or Metastatic Solid CarcinomasFrance, United States
-
Centre Leon BerardBayerActive, not recruitingMetastatic Cancer | Solid Tumor, Adult | Locally Advanced Solid TumorFrance
-
University Hospital, BordeauxCompletedLocally Advanced Basal Cell Carcinoma | Metastatic Basal Cell CarcinomaFrance
-
Assistance Publique Hopitaux De MarseilleUnknownElderly | Locally Advanced or Metastatic CancerFrance
-
National Cancer Institute (NCI)RecruitingLocally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States, Puerto Rico
-
Incyte CorporationCompletedLocally Advanced Solid Tumors | Metastatic Solid TumorsFrance, Spain, United States, China, United Kingdom, Lithuania, Germany, Ukraine, Finland, Italy, Belgium, Australia, Bulgaria, Latvia, New Zealand, Poland
-
Jiangsu HengRui Medicine Co., Ltd.CompletedLocally Advanced or Metastatic and Unresectable HCCUnited States, Spain, China, Taiwan, Belgium, Korea, Republic of, Italy, Hong Kong, Russian Federation, Ukraine, Turkey, Poland, Germany
-
Assistance Publique - Hôpitaux de ParisFederation Francophone de Cancerologie Digestive; UNICANCER; Merck Serono S.A... and other collaboratorsUnknownColon Cancer | Locally Advanced Malignant NeoplasmFrance
-
University Hospital, BordeauxRecruiting
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorUnited States, Australia, Taiwan, Spain, United Kingdom, Korea, Republic of, Italy, France, Singapore, Canada, Netherlands
-
Hospices Civils de LyonNot yet recruiting
-
AstraZenecaCompletedCaucasian Patients With EGFR Mutation Positive Advanced NSCLCBulgaria, Italy, Poland, Spain, Turkey, United Kingdom, Romania, Norway, Hungary, Portugal, Greece, Switzerland, France
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Thailand, France, Belgium, China, Germany, Greece, Argentina, Turkey, Malaysia, Portugal, Brazil, United States, Hungary, India
-
Hospices Civils de LyonCompletedLocally Advanced Breast Cancer | Ductal Histologic Type | Without Her 2 OverexpressionFrance
-
Novartis PharmaceuticalsTerminatedMetastatic Breast Cancer (MBC) | Inoperable Locally Advanced Breast CancerFrance, Spain
-
Institut Paoli-CalmettesSociété Francophone d'Onco-GériatrieUnknownAdvanced or Metastatic NSCLC | Advanced or Metastatic MelanomaFrance
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingLocally-advanced Rectal CancerFrance
-
European Organisation for Research and Treatment...PfizerCompletedLocally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma | Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor | Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 | Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma | Locally Advanced... and other conditionsFrance, Belgium, Netherlands, Germany, United Kingdom, Italy, Norway, Poland, Slovakia, Slovenia
-
Carrick Therapeutics LimitedBerlin-Chemie AG Menarini GroupRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerUnited States, Spain, France, United Kingdom
-
GERCOR - Multidisciplinary Oncology Cooperative...OSE ImmunotherapeuticsRecruitingMetastatic Cancer | Pancreatic Ductal Adenocarcinoma | Locally Advanced CancerFrance
-
Institut BergoniéMinistry of Health, France; PharmaMarTerminatedAdult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated LiposarcomaFrance
-
Hoffmann-La RocheCompletedLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, Korea, Republic of
-
BeiGeneActive, not recruitingNonsmall Cell Lung Cancer, Stage IV | Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC)United States, China, Korea, Republic of, France, Spain, Australia, Austria
-
Institut du Cancer de Montpellier - Val d'AurelleCompletedRectal Carcinoma | Locally Advanced Malignant NeoplasmFrance
-
BayerCompletedLocally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion | Infantile FibrosarcomaFrance